Finastra to divest Treasury & Capital Markets business to Apax Funds

By Gloria Methri

Finastra has signed an agreement to sell its Treasury and Capital Markets (TCM) business unit to an affiliate of private equity advisory firm Apax Partners LLP. Once the deal is complete, the TCM division will operate as an independent entity under a new brand.

The TCM division, which serves over 340 financial institutions worldwide, offers a suite of risk management, regulatory compliance, and capital markets solutions. Key products include Kondor, Summit, and Opics, all designed to manage the front-to-back trade lifecycle and support operational resilience for banks and financial institutions. With decades of intellectual property and a strong global client base, the TCM business is firmly embedded in the international banking ecosystem.

Finastra’s decision to divest TCM forms part of a broader strategy to streamline its product portfolio and reallocate capital to strengthen its core financial services software business.

“This sale marks an important milestone for Finastra that will help further launch our next phase of growth with a focused suite of mission-critical financial services software,” said Chris Walters, CEO at Finastra. “It will provide capital to accelerate our strategy and reinvest in our core business, while providing our award-winning TCM platform with the backing of an experienced, long-term technology investor to support its continued success moving forward.”

Following the sale, Apax Funds will support TCM’s evolution as a standalone company. The focus will be on accelerating product innovation, expanding cloud capabilities, and enhancing customer experience through strategic and operational improvements.

“TCM is a robust, mission-critical platform with leading functionality and an impressive customer base,” said Jason Wright, Partner at Apax. “We see significant potential to invest in technology, talent, and customer relationships to accelerate innovation and growth as a standalone company, drawing on our 25 years of experience scaling global software companies.”

Gabriele Cipparrone, Partner at Apax, added, “We are excited to partner with the TCM team as the business begins a new chapter as an independent organisation. With the backing of the Apax Funds, we expect TCM to benefit from accelerated innovation and enhanced operations, delivering even greater value to its clients.”

Apax Funds has a strong track record in enterprise software investments and corporate carve-outs. Previous investments include Paycor HCM, Zellis Group, ECi Software, OCS/Finwave, Azentio, EcoOnline, and IBS Software. The transaction is expected to close in the first half of 2026, subject to standard regulatory approvals and employee consultation processes where applicable. The financial terms of the deal were not disclosed.